Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
This study has been completed.
Sponsor:
Dr. Falk Pharma GmbH
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH
ClinicalTrials.gov Identifier:
NCT00747110
First received: September 3, 2008
Last updated: June 25, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2010 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |